Tleyjeh, IM;
Bin Abdulhak, AA;
Riaz, M;
Alasmari, FA;
Garbati, MA;
AlGhamdi, M;
Khan, AR;
Al Tannir, M;
Erwin, PJ;
Ibrahim, T;
et al.
Tleyjeh, IM; Bin Abdulhak, AA; Riaz, M; Alasmari, FA; Garbati, MA; AlGhamdi, M; Khan, AR; Al Tannir, M; Erwin, PJ; Ibrahim, T; Allehibi, A; Baddour, LM; Sutton, AJ
(2012)
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.
PLoS ONE, 7 (12).
e50836 -e50836 (12).
ISSN 1932-6203
https://doi.org/10.1371/journal.pone.0050836
SGUL Authors: Riaz, Muhammad
Preview |
|
["document_typename_application/pdf; charset=binary" not defined]
Published Version
Download (613kB)
| Preview
|
Abstract
Abstract
Introduction
Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI).
Methods
Ovid MEDLINE, EMBASE, ISI Web of Science, and Scopus were searched from 1990 to January 2012 for analytical studies that reported an adjusted effect estimate of the association between PPI use and CDI. We performed random-effect meta-analyses. We used the GRADE framework to interpret the findings.
Results
We identified 47 eligible citations (37 case-control and 14 cohort studies) with corresponding 51 effect estimates. The pooled OR was 1.65, 95% CI (1.47, 1.85), I2 = 89.9%, with evidence of publication bias suggested by a contour funnel plot. A novel regression based method was used to adjust for publication bias and resulted in an adjusted pooled OR of 1.51 (95% CI, 1.26–1.83). In a speculative analysis that assumes that this association is based on causality, and based on published baseline CDI incidence, the risk of CDI would be very low in the general population taking PPIs with an estimated NNH of 3925 at 1 year.
Conclusions
In this rigorously conducted systemic review and meta-analysis, we found very low quality evidence (GRADE class) for an association between PPI use and CDI that does not support a cause-effect relationship.
Item Type: |
Article
|
Additional Information: |
Copyright notice
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
Keywords: |
Clostridium difficile, Enterocolitis, Pseudomembranous, Humans, Incidence, Proton Pump Inhibitors, Risk |
SGUL Research Institute / Research Centre: |
Academic Structure > Population Health Research Institute (INPH) |
Journal or Publication Title: |
PLoS ONE |
ISSN: |
1932-6203 |
Related URLs: |
|
Dates: |
Date | Event |
---|
12 December 2012 | Published |
|
PubMed ID: |
23236397 |
Web of Science ID: |
23236397 |
|
Download EPMC Full text (PDF)
|
|
Download EPMC Full text (HTML)
|
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/105308 |
Publisher's version: |
https://doi.org/10.1371/journal.pone.0050836 |
Statistics
Item downloaded times since 31 Mar 2014.
Actions (login required)
|
Edit Item |